Filing Details

Accession Number:
0001140361-15-038714
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-10-27 19:15:32
Reporting Period:
2015-10-26
Filing Date:
2015-10-27
Accepted Time:
2015-10-27 19:15:32
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1302573 Oncomed Pharmaceuticals Inc OMED Pharmaceutical Preparations (2834) 383572512
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1553353 Austin Gurney C/O Oncomed Pharmaceuticals, Inc.
800 Chesapeake Drive
Redwood City CA 94063
See Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2015-10-26 14,000 $20.00 35,419 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person on June 29, 2015.
  2. Includes 20,000 restricted stock units. The Reporting Person is entitled to receive one (1) share of common stock for each one (1) restricted stock unit.